Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
or

Nasdaq Biotechnology Ishares ETF (IBB)

Nasdaq Biotechnology Ishares ETF (IBB)
130.75 x 2 132.07 x 19
Post-market by (Cboe BZX)
131.14 -1.83 (-1.38%) 03/26/25 [NASDAQ]
130.75 x 2 132.07 x 19
Post-market 131.14 unch (unch) 16:05 ET
Quote Overview for Wed, Mar 26th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
130.83
Day High
132.96
Open 132.95
Previous Close 132.97 132.97
Volume 600,600 600,600
Avg Vol 1,120,665 1,120,665
Stochastic %K 24.27% 24.27%
Weighted Alpha -6.75 -6.75
5-Day Change -3.43 (-2.55%) -3.43 (-2.55%)
52-Week Range 123.60 - 150.57 123.60 - 150.57
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fund Basics

See More
  • Fund Family BlackRock iShares
  • Assets Under Management 6,196,364,800
  • Shares Outstanding, K 47,250
  • 60-Month Beta 0.84
  • Price/Earnings ttm 15.68
  • Annual Dividend & Yield 0.38 (0.29%)
  • Most Recent Dividend 0.121 on 03/18/25
  • Management Fee 0.44%
  • INDUSTRY GROUPING:

    ETFs - Biotech

Options Overview Details

View History
  • Implied Volatility 19.91% ( +0.86%)
  • Historical Volatility 16.51%
  • IV Percentile 59%
  • IV Rank 27.70%
  • IV High 33.78% on 08/05/24
  • IV Low 14.59% on 07/10/24
  • Put/Call Vol Ratio 1.38
  • Today's Volume 1,282
  • Volume Avg (30-Day) 6,236
  • Put/Call OI Ratio 1.44
  • Today's Open Interest 110,326
  • Open Int (30-Day) 133,302

Price Performance

See More
Period Period Low Period High Performance
1-Month
130.83 +0.24%
on 03/26/25
Period Open: 137.04
138.46 -5.29%
on 02/27/25
-5.90 (-4.31%)
since 02/26/25
3-Month
130.81 +0.25%
on 01/13/25
Period Open: 134.67
142.80 -8.17%
on 02/06/25
-3.53 (-2.62%)
since 12/26/24
52-Week
123.60 +6.10%
on 04/19/24
Period Open: 135.87
150.57 -12.90%
on 09/19/24
-4.73 (-3.48%)
since 03/26/24

Most Recent Stories

More News
Corvus Pharma Stock Dips On Bigger-Than-Feared Q4 Loss, But Retail’s Faith Grows Stronger

Research and development expenses in the reported quarter rose by $2 million, primarily due to increased spending on the soquelitinib clinical trial for T-cell lymphoma.

CRVS : 3.35 (-14.76%)
VXF : 178.71 (-1.31%)
IBB : 131.14 (-1.38%)
AVSC : 49.62 (-0.74%)
Lexeo Therapeutics Sees Biggest Retail Follower Surge Among Biotech Stocks After Record-Breaking Rally: What's The Big Draw?

The company reported an adjusted Q4 loss of $0.78 per share, beating expectations for a $0.81 loss.

LXEO : 3.99 (-10.14%)
IBB : 131.14 (-1.38%)
VTI : 281.16 (-1.17%)
IWM : 205.59 (-1.02%)
BioNTech's 2025 Revenue View, Vaccine Policy Uncertainty Prompt Price-Target Cut: Retail Stays Cautiously Optimistic

For the current year, BioNTech projected revenue of 1.7 billion euros to 2.2 billion euros, below the market consensus of 2.54 billion euros and a fall from last year's 2.75 billion euros.

IBB : 131.14 (-1.38%)
FNDF : 36.87 (-0.81%)
PFE : 25.21 (-1.33%)
BNTX : 95.90 (-1.18%)
Editas Medicine Stock Slides After-Hours On Bigger-Than-Expected Q4 Loss, But Retail Bulls Eye M&A Potential

The company expects its current cash position and retained portions of payments from its agreement with Vertex to support operations into the second quarter of 2027.

IBB : 131.14 (-1.38%)
EDIT : 1.2700 (-2.31%)
VTI : 281.16 (-1.17%)
IWM : 205.59 (-1.02%)
4 Sectors That Thrive When Inflation Runs Hot

Sticky inflation and higher-for-longer interest rates is causing a rotation out of technology stocks, here are four sectors for investors hunting for value

MDLZ : 66.33 (+2.54%)
KMB : 139.61 (+1.91%)
MRK : 88.11 (+0.27%)
PG : 166.58 (+2.29%)
NEM : 47.39 (-0.34%)
IBB : 131.14 (-1.38%)
PEP : 148.64 (+2.13%)
FCX : 41.49 (-3.53%)
ABBV : 201.30 (-0.02%)
NEE : 69.73 (+1.66%)
PepGen Sees Fastest Weekly Retail Following Growth Among Biotech Stocks: What's Behind The Buzz?

The rally follows PepGen's release of early clinical data from its Phase 1 trial evaluating its therapy to treat a rare genetic disorder.

VXF : 178.71 (-1.31%)
IBB : 131.14 (-1.38%)
PEPG : 1.5700 (+3.97%)
IWM : 205.59 (-1.02%)
Solid Biosciences' Retail Following Swells Amid Stock's Best Run In A Year — What's Behind The Move?

Early-stage data from the company's gene therapy candidate SGT-003 for Duchenne muscular dystrophy (DMD) showed encouraging results.

SLDB : 4.26 (-5.12%)
VXF : 178.71 (-1.31%)
IBB : 131.14 (-1.38%)
VTI : 281.16 (-1.17%)
IWM : 205.59 (-1.02%)
Bio-Techne Stock Outlook: Is Wall Street Bullish or Bearish?

Despite Bio-Techne's underperformance relative to the broader market over the past year, Wall Street analysts remain bullish on the stock's prospects.

TECH : 59.38 (-1.00%)
$SPX : 5,712.20 (-1.12%)
IBB : 131.14 (-1.38%)
IBB : 131.14 (-1.38%)
Ascendis Pharma Eyes Best Open In A Month After Q4 Print, But BofA Cuts Price Target: Retail Gets Buzzing

The brokerage adjusted its 2025 Yorvipath sales forecast downward, expecting a more backloaded ramp.

TCAF : 32.86 (-1.02%)
ASND : 158.28 (-1.71%)
IBB : 131.14 (-1.38%)
HRTS : 29.51 (-1.47%)
Tempus AI Stock Swings Wildly As Earnings Near, Retail’s Cautiously Optimistic After Insider Sales

The company has gained a lot of attention since launching an AI-enabled personal health app last month.

ARKG : 22.49 (-4.26%)
IBB : 131.14 (-1.38%)
VTI : 281.16 (-1.17%)
TEM : 53.25 (-9.08%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Fund Summary

The iShares Nasdaq Biotechnology ETF seeks to track the investment results of an index composed of biotechnology and pharmaceutical equities listed on the NASDAQ. The Fund seeks investment results that correspond generally to the price and yield performance, before fees and expenses, of the NASDAQ Biotechnology...

See More

Key Turning Points

3rd Resistance Point 134.58
2nd Resistance Point 133.77
1st Resistance Point 132.46
Last Price 131.14
1st Support Level 130.33
2nd Support Level 129.52
3rd Support Level 128.20

See More

52-Week High 150.57
Fibonacci 61.8% 140.26
Fibonacci 50% 137.08
Fibonacci 38.2% 133.90
Last Price 131.14
52-Week Low 123.60

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Trading Volatility: How to Use IV Rank & Percentile for Smarter Options Strategies